The Federal Circuit's recent decision in Medtronic v. Edwards Lifesciences
highlights the importance of maintaining accurate priority claims
in patent applications, particularly those with multiple
generations of priority.
In Medtronic, the asserted patent claimed priority to a
French application (application A) an international application
(application B), and a series of three U.S. applications
(applications C, D, and E). While the priority claim was stated
correctly in the asserted patent, the priority claims in the
earlier-filed U.S. applications contained various deficiencies. For
example, application D incorrectly stated that it was a
continuation-in-part of application B, skipping over intervening
application C. Apparently, the applicant had reused the priority
language from application C when filing application D, without
updating the priority claim to include application C. Application E
suffered from the same defect (skipping intermediate applications C
and